197results about How to "Increase alertness" patented technology

A tissue stimulation system that generates an electrical tissue stimulation signal configured to reduce tissue impedance and increase depth of signal penetration. The use of leads is dynamically controlled and altered between conducting biopotential voltages, conducting electrical tissue stimulation signals, and grounding, in response to a computational analysis of biopotential data acquired from a region of tissue to be stimulated.

Portable transdermal electrical stimulation (TES) applicators for modifying a subject's cognitive state. In general, the portable applicators described are specifically configured and adapted to be lightweight and may be wearable, and to deliver a high-intensity TES able to evoke or enhance a predetermined cognitive effect. These TES applicators may include a pair of electrodes and a TES control module comprising a processor, a timer and a waveform generator. TES control module is adapted to deliver a biphasic electrical stimulation signal of 10 seconds or longer between the first and second electrodes having a frequency of 400 Hz or greater, a duty cycle of greater than 10 percent, an intensity of 3 mA or greater, with a DC offset.

A new routing protocol for routing service requests in a contact center is provided that takes into account agent preferences. Agents identify their preferences for handling particular types of service requests. The routing protocol takes account of those preferences while still routing calls in a systematic, coordinated and efficient manner. Additionally, management may communicate incentives dynamically to agents to incentivize agents to change their preferences in ways that corresponds to management priorities. Management may further influence routing by adjusting management preferences, which may be taken into account along with agent preferences when routing calls. By incorporating agent preferences in the routing scheme, agents are given more control over their work, thus tending to increase job satisfaction and therefore agent retention and contact-center performance.

This invention provides compositions, methods and process of producing extracts from Xanthoceras sorbifolia. The extract comprises alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, saponins, tannins, acid, flavonoids and others. The composition can be used for treating cancer, arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, dizziness, kidney disorder, impotence and premature ejaculation; for preventing cerebral aging; for improving memory, cerebral functions; or for curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease, autism, brain trauma, Parkinson's disease or other diseases caused by cerebral dysfunctions, and treating arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, dizziness, kidney disorder. This invention provides compounds comprising at least one sugar, a triterpene, such as Sapogenin, and at least one side chains at Carbon 21 and 22, such as Angeloyl groups. The compounds of the present have various pharmaceutical and therapeutic applications.

This invention provides compositions, methods and process of producing extracts from Xanthoceras sorbifolia. The extract comprises alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, saponins, tannins, acid, flavonoids and others. The composition can be used for treating breast, leukocyte, liver, ovarian, bladder, prostate, bone or brain cancer. This invention provides compounds comprising at least one sugar, a triterpene, such as Sapogenin, and at least one side chains at Carbon 21 and 22, such as Angeloyl groups. The compounds of the present have various pharmaceutical and therapeutic applications, including treating breast, leukocyte, liver, ovarian, bladder, prostate, bone or brain cancer.

This invention provides compositions, methods and process of producing extracts and pure compounds from Xanthoceras sorbifolia. The extract comprises saponins and other constituents including alkaloids, coumarins, saccharides, proteins, polysaccharides, glycosides, tannins, acid, flavonoids and others. The composition can be used for treating cancer and other conditions, such as arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, coronary heart disease, headache, kidney disorder, and impotence; for improving cerebral functions; or for curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease, autism, brain trauma, Parkinson's, cerebral dysfunctions, and treating arthritis, rheumatism, poor circulation, arteriosclerosis, Raynaud's syndrome, angina pectoris, cardiac disorder, headache, dizziness, kidney disorder. This invention provides compounds of oleanene triterpenoidal saponin in nature with the characteristics that at least one angeloyl group attached to Carbon 21 or / and 22, or / and linked to the sugar. The compounds of the present invention have various pharmaceutical and therapeutic applications.

The invention relates to a road deceleration interlaced vision marked line method, which comprises at least two lane road marked lines which are regarded as parallel lines along a traffic direction on a road, two oblique lines which are symmetrically arranged are respectively crossed with acute angles of the two parallel lines, ends which are arranged on the middle portions of the two parallel lines are connected by a transverse line which is perpendicular to the parallel lines, a section of an interlaced vision marked line are formed by an oblique line which is crossed by the two acute angles and the connecting parallel lines between the parallel lines, and a plurality of groups of equi-spaced interlaced vision marked line sections are arranged on the interval of the road with a certain length to form the road deceleration interlaced vision marked line. The road deceleration interlaced vision marked line has important roles at the aspects of increasing the visibility, reducing the vehicle speed and reducing the accident rate and the like, is capable of increasing the highlighting of road dangerous sections (intersections) and increasing the alertness of drivers, the conscious deceleration effect of the drivers is obvious, and the road deceleration interlaced vision marked line method has the practical value of preventing and reducing the happen of traffic accidents. The deceleration interlaced vision marked line method is capable of being used for the safe design and improvement of a road intersection, a traffic accident black-spot or a road section.

The invention provides a lighting unit configured to generate white light wherein the white light has a spectral intensity in the visible wherein at least 40% of all photons in the wavelength range of 400-500 nm are found in the wavelength range of 430-445 nm (see also FIG. 1b). The lighting unit may especially be used for increasing alertness of a human while not or minimally suppressing melatonin production of the human.